flu vaccine related Press Releases
Researchers identify key peptides that could lead to a universal vaccine for influenza
Researchers identify key peptides that could lead to a universal vaccine for influenza 31-Jan-2012 Researchers at the University of Southampton, University of Oxford and Retroscreeen Virology Ltd Read more...
VaxInnate Licenses Recombinant Flu Vaccines to CJ CheilJedang Corporation of South Korea
Agreement covers region with a population of 650 million individuals CRANBURY, N.J.--(BUSINESS WIRE)-- VaxInnate Corporation announced today that it has granted biopharmaceutical company CJ Read more...
First U.S. cell-based flu vaccine plant set for dedication
Facility’s ability to produce cell-based pandemic flu vaccine marks historic change WASHINGTON--(BUSINESS WIRE)-- The first U.S. facility to use a faster and more flexible technology to make Read more...
Medicago Announces 2011 Third Quarter Financial Results
QUEBEC CITY, Nov. 14, 2011 /PRNewswire/ - Medicago Inc. (TSX: MDG), a biotechnology company focused on developing highly effective and competitive vaccines based on proprietary manufacturing Read more...
Sinovac Selected by Beijing CDC to Supply Seasonal Influenza Vaccine Anflu(R) to Beijing Citizens
BEIJING, Oct. 13, 2011 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (Nasdaq: SVA), a leading provider of biopharmaceutical products in China, announced today that it has been selected by the Beijing Read more...
Fred Meyer to Offer Needle-Free Flu Vaccines for First Time
Select stores will use the Biojector® 2000 from Portland-based Bioject Medical Technologies Inc. PORTLAND, Ore.--(BUSINESS WIRE)-- Fred Meyer customers now have a needle-free option to be immunized Read more...
Medicago announces 2011 second quarter financial results
QUEBEC CITY, QC, Aug. 12, 2011 /PRNewswire/ - Medicago Inc. (TSX: MDG), a biotechnology company focused on developing highly effective and affordable vaccines based on proprietary manufacturing Read more...
Medicago reports positive Phase II final results for its avian flu pandemic vaccine
- Phase II part B confirms results obtained in Phase II part A - - Company's results continue to be amongst the best for influenza vaccine manufacturing technologies - QUEBEC CITY, June 30, 2011 Read more...
NanoBio® Announces First Patients Vaccinated in Phase 1b Intranasal Influenza Vaccine Study
ANN ARBOR, Mich.--(BUSINESS WIRE)-- Building upon a series of successful preclinical and clinical studies, NanoBio Corporation today announced the initiation of a second tolerability and Read more...
VaxInnate Awarded Contract by the U.S. Government To Develop Recombinant Seasonal and Pandemic Flu Vaccines
Potential Value of Contract as High as $196 Million CRANBURY, N.J.--(BUSINESS WIRE)-- VaxInnate Corporation today announced that it has been awarded a contract by the Biomedical Advanced Research and Read more...
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
